Doozio Posted - 04/23/24

$CRNX no faatch 💣s land n this shud easily be 🧠⏰♾️ if not MOAR.

reveultoL Posted - 04/16/24

$CRNX no worries, heading the right direction

Jahanamanan Posted - 04/15/24

$CRNX is this a mini LLY? Good buy long term? Heard about this company on CNBC

fda_tracker Posted - 04/15/24

$CRNX Phase 2 trial w/est Apr completion date NCT05361668: https://www.clinicaltrials.gov/study/NCT05361668 Trial Tracker: https://www.fdatracker.com/trial-tracker/

Llamado Posted - 04/15/24

$CRNX More from those unusual option activity posts in discord. A little bearish momentum still so could do 43.2-41.5 (161.8 fib to channel bottom) but trending well.

Stock_Titan Posted - 04/11/24

$CRNX Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/CRNX/crinetics-pharmaceuticals-announces-april-2024-inducement-grants-9ct3524w7zlt.html

lob11 Posted - 04/11/24

$CRNX

insiderbuyingselling Posted - 04/08/24

$CRNX new insider selling: 40951 shares. http://insiderbuyingselling.com/?t=CRNX

RonIsWrong Posted - 04/04/24

$CRNX anyone know if this is meaningful? I haven't heard of this before.

greenype Posted - 04/04/24

$CRNX

Stoop_Kid Posted - 04/03/24

$ROIV $CRNX $NL $CG

FlynancialAnalyst Posted - 04/03/24

$CRNX 🐂🚀s

jewell69 Posted - 04/03/24

$CRNX watching pediatric oncology Michelle Ross touted it on CNBC (WHO'S SHE)

G101SPM Posted - 04/03/24

$CRNX $47.77 bid. DAC $43.53. EXIT $75.00. STATEMENT: Live On CNBC, StemPoint Capital CIO Michelle Ross Mentions Crinetics Pharmaceuticals As A GLP-1 Adjacent Play During Halftime Segment 'Opportunities In Biotech' Calling It Her "Best Biotech Idea."

RonIsWrong Posted - 04/03/24

$CRNX new all time high

RonIsWrong Posted - 04/03/24

$CRNX Live On CNBC, StemPoint Capital CIO Michelle Ross Mentions Crinetics Pharmaceuticals As A GLP-1 Adjacent Play During Halftime Segment 'Opportunities In Biotech' Calling It Her "Best Biotech Idea"

1logicaltrader Posted - 04/03/24

$ATNF in it for a trade since Tuesday morning dips. Along with $LIFW and $CRNX

Backshoream Posted - 04/03/24

$ALT talking up $CRNX on CNBC

Doozio Posted - 4 weeks ago

$CRNX huckleberries above da $$$ pattern n 8 moar 🐑 until 🧠⏰♾️?

helmethead Posted - 1 month ago

@lustitia @Retail_Lives_Matter I was waiting for the 8k. Hopefully I’ll get around to it by tomorrow. Something stinks here. Trying hard to understand the role of Weston Nicholes and possibly $CRNX in this convoluted mess.

G101SPM Posted - 03/28/24

$CRNX $45.91 +1.48. DAC (dollar average cost) $43.53. EXIT $75.00. UPDATE: JMP Securities analyst Jonathan Wolleben reiterates Crinetics Pharmaceuticals(CRNX) with a Market Outperform and maintains $80 price target.

FlynancialAnalyst Posted - 03/26/24

Here is $VKTX short float trend in the months leading up to the advance, similar to $CRNX

FlynancialAnalyst Posted - 03/26/24

$CRNX $3.36B mc $XBI name with significant accumulation last wk off 10 wk SMA just above $40. Fully institutionally owned, short float % steadily declining over the past 6 months. #SqueezeIt .. similar setup to $VKTX a few months b4 breakout

Doozio Posted - 03/23/24

$CRNX like when a 🧠👀 becomes 🧠⏰?

howardlindzon Posted - 03/23/24

$CRNX endocrine...hmm..600 followers and all time highs In biotech

Quantumup Posted - 03/21/24

JMP Securities ~Mar 20~ ⬆️PT $CRNX $80 was $60/Mkt Outperform; says ‘‘Paltusotine is Faster, Better, and More Convenient:’’ Oral Tx PATHFNDR-2 data > expected w/ an IGF-1 response rate > the💉SRLs. JMP thinks approval is likely=90% PoS;⬆️peak WW sales estimates to $840M was $450M.

Rkramden60 Posted - 03/20/24

$CRNX loading up on this and $LENZ tomorrow. LENZ is the new ticker for $LENZ which should happen on Friday. Phase 3 decision soon for best in class drops for Presbyopia.

AnaChart Posted - 03/20/24

$CRNX https://anachart.com/wp-content/uploads/ana_temp/1710943299_soc-img.jpg

OpenOutcrier Posted - 03/20/24

$CRNX (-2.6% pre) Form S-3ASR Crinetics Pharmaceutical https://ooc.bz/l/28174

erevnon Posted - 03/20/24

JonesTrading maintains Crinetics Pharmaceuticals $CRNX at Buy and raises the price target from $52 to https://marketsblock.com/stock-upgrades-and-downgrades/